These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Living patches engineered from human umbilical cord derived fibroblasts and endothelial progenitor cells. Schmidt D; Mol A; Neuenschwander S; Breymann C; Gössi M; Zund G; Turina M; Hoerstrup SP Eur J Cardiothorac Surg; 2005 May; 27(5):795-800. PubMed ID: 15848316 [TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor β, bone morphogenetic protein, and vascular endothelial growth factor mediate phenotype maturation and tissue remodeling by embryonic valve progenitor cells: relevance for heart valve tissue engineering. Chiu YN; Norris RA; Mahler G; Recknagel A; Butcher JT Tissue Eng Part A; 2010 Nov; 16(11):3375-83. PubMed ID: 20629541 [TBL] [Abstract][Full Text] [Related]
24. Serum derived from multiple trauma patients promotes the differentiation of endothelial progenitor cells in vitro: possible role of transforming growth factor-beta1 and vascular endothelial growth factor165. Henrich D; Hahn P; Wahl M; Wilhelm K; Dernbach E; Dimmeler S; Marzi I Shock; 2004 Jan; 21(1):13-6. PubMed ID: 14676678 [TBL] [Abstract][Full Text] [Related]
25. Bioactive porcine matrices in heart valve tissue engineering. Somers P; de Somer F; Cornelissen M; Thierens H; Van Nooten G J Heart Valve Dis; 2012 Jul; 21(4):535-43. PubMed ID: 22953684 [TBL] [Abstract][Full Text] [Related]
26. Construction of an autologous tissue-engineered venous conduit from bone marrow-derived vascular cells: optimization of cell harvest and seeding techniques. Roh JD; Brennan MP; Lopez-Soler RI; Fong PM; Goyal A; Dardik A; Breuer CK J Pediatr Surg; 2007 Jan; 42(1):198-202. PubMed ID: 17208565 [TBL] [Abstract][Full Text] [Related]
27. Angiogenic modulators in valve development and disease: does valvular disease recapitulate developmental signaling pathways? Shworak NW Curr Opin Cardiol; 2004 Mar; 19(2):140-6. PubMed ID: 15075741 [TBL] [Abstract][Full Text] [Related]
28. Opposite effects of transforming growth factor-β1 and vascular endothelial growth factor on the degeneration of aortic valvular interstitial cell are modified by the extracellular matrix protein fibronectin: implications for heart valve engineering. Gwanmesia P; Ziegler H; Eurich R; Barth M; Kamiya H; Karck M; Lichtenberg A; Akhyari P Tissue Eng Part A; 2010 Dec; 16(12):3737-46. PubMed ID: 20673026 [TBL] [Abstract][Full Text] [Related]
29. Endothelial progenitor cells as a sole source for ex vivo seeding of tissue-engineered heart valves. Sales VL; Mettler BA; Engelmayr GC; Aikawa E; Bischoff J; Martin DP; Exarhopoulos A; Moses MA; Schoen FJ; Sacks MS; Mayer JE Tissue Eng Part A; 2010 Jan; 16(1):257-67. PubMed ID: 19698056 [TBL] [Abstract][Full Text] [Related]
30. Chondrogenic differentiation of human adipose-derived stem cells in polyglycolic acid mesh scaffolds under dynamic culture conditions. Mahmoudifar N; Doran PM Biomaterials; 2010 May; 31(14):3858-67. PubMed ID: 20153043 [TBL] [Abstract][Full Text] [Related]
38. A small diameter elastic blood vessel wall prepared under pulsatile conditions from polyglycolic acid mesh and smooth muscle cells differentiated from adipose-derived stem cells. Wang C; Cen L; Yin S; Liu Q; Liu W; Cao Y; Cui L Biomaterials; 2010 Feb; 31(4):621-30. PubMed ID: 19819545 [TBL] [Abstract][Full Text] [Related]
39. Composite implantation of mesenchymal stem cells with endothelial progenitor cells enhances tissue-engineered bone formation. Usami K; Mizuno H; Okada K; Narita Y; Aoki M; Kondo T; Mizuno D; Mase J; Nishiguchi H; Kagami H; Ueda M J Biomed Mater Res A; 2009 Sep; 90(3):730-41. PubMed ID: 18570318 [TBL] [Abstract][Full Text] [Related]